Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Population-level effectiveness of PMTCT Option A on early mother-to-child (MTCT) transmission of HIV in South Africa: implications for eliminating MTCT.

Goga AE, Dinh TH, Jackson DJ, Lombard CJ, Puren A, Sherman G, Ramokolo V, Woldesenbet S, Doherty T, Noveve N, Magasana V, Singh Y, Ramraj T, Bhardwaj S, Pillay Y; South Africa PMTCT Evaluation (SAPMCTE) Team..

J Glob Health. 2016 Dec;6(2):020405.

2.

Efficacy of Six-Week Extended-Dose Nevirapine Varies by Infant Birth Weight with Greatest Relative Efficacy in Low Birth Weight Infants.

Gupte N, Kinikar A, McIntire KN, Bhosale R, Patil S, Suryavanshi N, Mave V, Kulkarni V, Bollinger RC, Gupta A.

PLoS One. 2016 Sep 30;11(9):e0162979. doi: 10.1371/journal.pone.0162979.

3.

A systematic review of interventions to improve postpartum retention of women in PMTCT and ART care.

Geldsetzer P, Yapa HM, Vaikath M, Ogbuoji O, Fox MP, Essajee SM, Negussie EK, Bärnighausen T.

J Int AIDS Soc. 2016 Apr 25;19(1):20679. doi: 10.7448/IAS.19.1.20679. Review.

5.

Antiretroviral therapy provided to HIV-infected Malawian women in a randomized trial diminishes the positive effects of lipid-based nutrient supplements on breast-milk B vitamins.

Allen LH, Hampel D, Shahab-Ferdows S, York ER, Adair LS, Flax VL, Tegha G, Chasela CS, Kamwendo D, Jamieson DJ, Bentley ME.

Am J Clin Nutr. 2015 Dec;102(6):1468-74. doi: 10.3945/ajcn.114.105106.

6.

Soluble CD14: An Independent Biomarker for the Risk of Mother-to-Child Transmission of HIV in a Setting of Preexposure and Postexposure Antiretroviral Prophylaxis.

Shivakoti R, Gupta A, Ray JC, Uprety P, Gupte N, Bhosale R, Mave V, Patil S, Balasubramanian U, Kinikar A, Bharadwaj R, Bollinger RC, Persaud D.

J Infect Dis. 2016 Mar 1;213(5):762-5. doi: 10.1093/infdis/jiv479.

PMID:
26443598
7.

Virologic and immunologic failure, drug resistance and mortality during the first 24 months postpartum among HIV-infected women initiated on antiretroviral therapy for life in the Mitra plus Study, Dar es Salaam, Tanzania.

Ngarina M, Kilewo C, Karlsson K, Aboud S, Karlsson A, Marrone G, Leyna G, Ekström AM, Biberfeld G.

BMC Infect Dis. 2015 Apr 8;15:175. doi: 10.1186/s12879-015-0914-z.

8.

Evaluation of adherence measures of antiretroviral prophylaxis in HIV exposed infants in the first 6 weeks of life.

Desmond AC, Moodley D, Conolly CA, Castel SA, Coovadia HM.

BMC Pediatr. 2015 Mar 19;15:23. doi: 10.1186/s12887-015-0340-9.

9.

Prevention of mother-to-child transmission of HIV type 1: the role of neonatal and infant prophylaxis.

Hurst SA, Appelgren KE, Kourtis AP.

Expert Rev Anti Infect Ther. 2015 Feb;13(2):169-81. doi: 10.1586/14787210.2015.999667. Review.

10.

Evaluation of a community health worker intervention and the World Health Organization's Option B versus Option A to improve antenatal care and PMTCT outcomes in Dar es Salaam, Tanzania: study protocol for a cluster-randomized controlled health systems implementation trial.

Sando D, Geldsetzer P, Magesa L, Lema IA, Machumi L, Mwanyika-Sando M, Li N, Spiegelman D, Mungure E, Siril H, Mujinja P, Naburi H, Chalamilla G, Kilewo C, Ekström AM, Fawzi WW, Bärnighausen TW.

Trials. 2014 Sep 15;15:359. doi: 10.1186/1745-6215-15-359.

11.

PedVacc 002: a phase I/II randomized clinical trial of MVA.HIVA vaccine administered to infants born to human immunodeficiency virus type 1-positive mothers in Nairobi.

Njuguna IN, Ambler G, Reilly M, Ondondo B, Kanyugo M, Lohman-Payne B, Gichuhi C, Borthwick N, Black A, Mehedi SR, Sun J, Maleche-Obimbo E, Chohan B, John-Stewart GC, Jaoko W, Hanke T.

Vaccine. 2014 Oct 7;32(44):5801-8. doi: 10.1016/j.vaccine.2014.08.034.

12.

Maternal pneumococcal capsular IgG antibodies and transplacental transfer are low in South Asian HIV-infected mother-infant pairs.

Gupta A, Mathad JS, Yang WT, Singh HK, Gupte N, Mave V, Bharadwaj R, Zaman K, Roy E, Bollinger RC, Bhosale R, Steinhoff MC.

Vaccine. 2014 Mar 14;32(13):1466-72. doi: 10.1016/j.vaccine.2014.01.033.

13.

Antiretroviral pharmacokinetics in mothers and breastfeeding infants from 6 to 24 weeks post-partum: results of the BAN Study.

Corbett AH, Kayira D, White NR, Davis NL, Kourtis AP, Chasela C, Martinson F, Phiri G, Musisi B, Kamwendo D, Hudgens MG, Hosseinipour MC, Nelson JA, Ellington SR, Jamieson DJ, van der Horst C, Kashuba A; BAN Study Team..

Antivir Ther. 2014;19(6):587-95. doi: 10.3851/IMP2739.

14.

Impact of maternal hepatitis B virus coinfection on mother-to-child transmission of HIV.

Mave V, Kadam D, Kinikar A, Gupte N, Bhattacharya D, Bharadwaj R, McIntire K, Kulkarni V, Balasubramanian U, Suryavanshi N, Thio C, Deshpande P, Sastry J, Bollinger R, Gupta A, Bhosale R; SWEN India and Byramjee-Jeejeebhoy Medical College Clinical Trials Unit Study team..

HIV Med. 2014 Jul;15(6):347-54. doi: 10.1111/hiv.12120.

15.

Effects of postnatal interventions for the reduction of vertical HIV transmission on infant growth and non-HIV infections: a systematic review.

Zunza M, Mercer GD, Thabane L, Esser M, Cotton MF.

J Int AIDS Soc. 2013 Dec 20;16:18865. doi: 10.7448/IAS.16.1.18865. Review.

16.

Addressing standards of care in resource-limited settings.

Dawson L, Klingman KL, Marrazzo J.

J Acquir Immune Defic Syndr. 2014 Jan 1;65 Suppl 1:S10-4. doi: 10.1097/QAI.0000000000000033.

17.

Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial.

Fowler MG, Coovadia H, Herron CM, Maldonado Y, Chipato T, Moodley D, Musoke P, Aizire J, Manji K, Stranix-Chibanda L, Fawzi W, Chetty V, Msweli L, Kisenge R, Brown E, Mwatha A, Eshleman SH, Richardson P, Allen M, George K, Andrew P, Zwerski S, Mofenson LM, Jackson JB; HPTN 046 Protocol Team..

J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):366-74. doi: 10.1097/QAI.0000000000000052.

18.

Evolving uses of oral reverse transcriptase inhibitors in the HIV-1 epidemic: from treatment to prevention.

Gupta RK, Van de Vijver DA, Manicklal S, Wainberg MA.

Retrovirology. 2013 Jul 31;10:82. doi: 10.1186/1742-4690-10-82. Review.

19.

The oral mucosa immune environment and oral transmission of HIV/SIV.

Wood LF, Chahroudi A, Chen HL, Jaspan HB, Sodora DL.

Immunol Rev. 2013 Jul;254(1):34-53. doi: 10.1111/imr.12078. Review.

20.

What is needed to eliminate new pediatric HIV infections: the contribution of model-based analyses.

Doherty K, Ciaranello A.

Curr Opin HIV AIDS. 2013 Sep;8(5):457-66. doi: 10.1097/COH.0b013e328362db0d. Review.

Items per page

Supplemental Content

Support Center